{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:04:16Z","timestamp":1793329456822,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00270-023-03403-3","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T19:02:54Z","timestamp":1680030174000},"page":"1221-1230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cost-Effectiveness of Drug-Coated Balloon Angioplasty versus Plain Old Balloon Angioplasty for Arteriovenous Fistula Stenosis"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-0296","authenticated-orcid":false,"given":"Alice L.","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Youm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"3403_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.ajkd.2018.01.034","volume":"72","author":"M Thamer","year":"2018","unstructured":"Thamer M, Lee TC, Wasse H, et al. Medicare costs associated with arteriovenous fistulas among US Hemodialysis Patients. Am J Kidney Dis. 2018;72:10\u20138.","journal-title":"Am J Kidney Dis"},{"key":"3403_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1914617","volume":"383","author":"RA Lookstein","year":"2020","unstructured":"Lookstein RA, Haruguchi H, Ouriel K, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med. 2020;383:733\u201342.","journal-title":"N Engl J Med"},{"issue":"8","key":"3403_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jvir.2022.03.606","volume":"33","author":"A Holden","year":"2022","unstructured":"Holden A, Haruguchi H, Suemitsu K, et al. IN.PACT AV access randomized trial: 12-month clinical results demonstrating the sustained treatment effect of drug-coated balloons. J Vasc Interv Radiol 2022;33(8):884\u201394.e7.","journal-title":"J Vasc Interv Radiol"},{"key":"3403_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/bjs\/znab301","volume":"108","author":"H Hu","year":"2021","unstructured":"Hu H, Tan Q, Wang J, Liu Y, Yang Y, Zhao J. Drug-coated balloon angioplasty for failing haemodialysis access: meta-analysis of randomized clinical trials. Br J Surg. 2021;108:1293\u2013303.","journal-title":"Br J Surg"},{"key":"3403_CR5","doi-asserted-by":"crossref","unstructured":"Han A, Park T, Kim HJ, Min S, Ha J, Min SK. Editor's choice\u2014paclitaxel coated balloon angioplasty vs. plain balloon angioplasty for haemodialysis arteriovenous access stenosis: a systematic review and a time to event meta-analysis of randomised controlled Trials. Eur J Vasc Endovasc Surg 2021; 62:597\u2013609.","DOI":"10.1016\/j.ejvs.2021.05.043"},{"key":"3403_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.kint.2021.02.040","volume":"100","author":"N Karunanithy","year":"2021","unstructured":"Karunanithy N, Robinson EJ, Ahmad F, et al. A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulas. Kidney Int. 2021;100:447\u201356.","journal-title":"Kidney Int"},{"key":"3403_CR7","doi-asserted-by":"crossref","unstructured":"Trerotola SO, Saad TF, Roy-Chaudhury P, Lutonix AVCTI. The Lutonix AV Randomized trial of paclitaxel-coated balloons in arteriovenous fistula stenosis: 2-year results and subgroup analysis. J Vasc Interv Radiol 2020; 31:1\u201314 e5.","DOI":"10.1016\/j.jvir.2019.08.035"},{"key":"3403_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/0886022X.2022.2029487","volume":"44","author":"C Luo","year":"2022","unstructured":"Luo C, Liang M, Liu Y, Zheng D, He Q, Jin J. Paclitaxel coated balloon versus conventional balloon angioplasty in dysfunctional dialysis arteriovenous fistula: a systematic review and meta-analysis of randomized controlled trials. Ren Fail. 2022;44:155\u201370.","journal-title":"Ren Fail"},{"key":"3403_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ejrad.2014.11.037","volume":"84","author":"PM Kitrou","year":"2015","unstructured":"Kitrou PM, Katsanos K, Spiliopoulos S, Karnabatidis D, Siablis D. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472). Eur J Radiol. 2015;84:418\u201323.","journal-title":"Eur J Radiol"},{"issue":"8","key":"3403_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jvir.2022.04.014","volume":"33","author":"JB Pietzsch","year":"2022","unstructured":"Pietzsch JB, Geisler BP, Manda B et al. IN.PACT AV Access trial: economic implications of drug-coated balloon treatment for dysfunctional arteriovenous fistulas. J Vasc Interv Radiol 2022;33(8):895\u2013902.e4","journal-title":"J Vasc Interv Radiol"},{"key":"3403_CR11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"GD Sanders","year":"2016","unstructured":"Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316:1093\u2013103.","journal-title":"JAMA"},{"key":"3403_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12889-021-12491-0","volume":"22","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Public Health. 2022;22:179.","journal-title":"BMC Public Health"},{"key":"3403_CR13","unstructured":"Kuntz K, Sainfort F, Butler M, et al. Decision and simulation modeling in systematic reviews. Rockville (MD), 2013. Report No.: 11(13)-EHC037-EF."},{"key":"3403_CR14","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2020.010101","volume":"30","author":"A Coskun","year":"2020","unstructured":"Coskun A, Oosterhuis WP. Statistical distributions commonly used in measurement uncertainty in laboratory medicine. Biochem Med (Zagreb). 2020;30: 010101.","journal-title":"Biochem Med (Zagreb)"},{"key":"3403_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1056\/NEJMp1405158","volume":"371","author":"PJ Neumann","year":"2014","unstructured":"Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371:796\u20137.","journal-title":"N Engl J Med"},{"key":"3403_CR16","doi-asserted-by":"crossref","unstructured":"Trerotola SO, Lawson J, Roy-Chaudhury P, Saad TF, Lutonix AVCTI. Drug coated balloon angioplasty in failing av fistulas: a randomized controlled trial. Clin J Am Soc Nephrol. 2018; 13:1215\u201324.","DOI":"10.2215\/CJN.14231217"},{"key":"3403_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5301\/jva.5000723","volume":"18","author":"S Yang","year":"2017","unstructured":"Yang S, Lok C, Arnold R, Rajan D, Glickman M. Comparison of post-creation procedures and costs between surgical and an endovascular approach to arteriovenous fistula creation. J Vasc Access. 2017;18:8\u201314.","journal-title":"J Vasc Access"},{"key":"3403_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000502507","volume":"50","author":"RJ Nordyke","year":"2019","unstructured":"Nordyke RJ, Reichert H, Bylsma LC, et al. Costs attributable to arteriovenous fistula and arteriovenous graft placements in hemodialysis patients with medicare coverage. Am J Nephrol. 2019;50:320\u20138.","journal-title":"Am J Nephrol"},{"key":"3403_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/SLA.0b013e31822f4e9b","volume":"255","author":"SE Rosas","year":"2012","unstructured":"Rosas SE, Feldman HI. Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis. Ann Surg. 2012;255:181\u20136.","journal-title":"Ann Surg"},{"key":"3403_CR20","doi-asserted-by":"publisher","first-page":"A731","DOI":"10.1016\/j.jval.2016.09.2202","volume":"19","author":"J Shafrin","year":"2016","unstructured":"Shafrin J, May S, Skrnick M, et al. Use of net monetary benefit analysis to comprehensively understand the value of innovative treatments. Value In Health. 2016;19:A731.","journal-title":"Value In Health"},{"key":"3403_CR21","doi-asserted-by":"crossref","unstructured":"Salisbury AC, Li H, Vilain KR et al. Cost-effectiveness of endovascular femoropopliteal intervention using drug-coated balloons versus standard percutaneous transluminal angioplasty: results from the IN.PACT SFA II Trial. JACC Cardiovasc Interv 2016; 9:2343\u201352.","DOI":"10.1016\/j.jcin.2016.08.036"},{"key":"3403_CR22","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462321000532","volume":"37","author":"A Etangsale","year":"2021","unstructured":"Etangsale A, Nunno L, Pineau J, Prognon P, Martelli N. Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review. Int J Technol Assess Health Care. 2021;37: e79.","journal-title":"Int J Technol Assess Health Care"},{"key":"3403_CR23","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","volume":"396","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Farah A, Ohlow MA, et al. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet. 2020;396:1504\u201310.","journal-title":"Lancet"},{"key":"3403_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/clc.22130","volume":"36","author":"M Dorenkamp","year":"2013","unstructured":"Dorenkamp M, Boldt J, Leber AW, et al. Cost-effectiveness of paclitaxel-coated balloon angioplasty in patients with drug-eluting stent restenosis. Clin Cardiol. 2013;36:407\u201313.","journal-title":"Clin Cardiol"},{"key":"3403_CR25","unstructured":"United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD."},{"key":"3403_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s12882-020-02135-7","volume":"21","author":"ES Ferreira","year":"2020","unstructured":"Ferreira ES, Moreira TR, da Silva RG, et al. Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort. BMC Nephrol. 2020;21:502.","journal-title":"BMC Nephrol"},{"key":"3403_CR27","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","volume":"73","author":"PA Schneider","year":"2019","unstructured":"Schneider PA, Laird JR, Doros G, et al. Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon. J Am Coll Cardiol. 2019;73:2550\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"3403_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","volume":"12","author":"JA Laird","year":"2019","unstructured":"Laird JA, Schneider PA, Jaff MR, et al. Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions. Circ Cardiovasc Interv. 2019;12: e007702.","journal-title":"Circ Cardiovasc Interv"},{"key":"3403_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011245","volume":"7","author":"K Katsanos","year":"2018","unstructured":"Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7: e011245.","journal-title":"J Am Heart Assoc"},{"key":"3403_CR30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/1526602819872154","volume":"26","author":"K Dinh","year":"2019","unstructured":"Dinh K, Limmer AM, Paravastu SCV, et al. Mortality after paclitaxel-coated device use in dialysis access: a systematic review and meta-analysis. J Endovasc Ther. 2019;26:600\u201312.","journal-title":"J Endovasc Ther"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-023-03403-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-023-03403-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-023-03403-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T18:03:01Z","timestamp":1693504981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-023-03403-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["3403"],"URL":"https:\/\/doi.org\/10.1007\/s00270-023-03403-3","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"18 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. Institutional Review Board approval is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or animal participants"}},{"value":"For this type of study, informed consent is not required. For this type of study, consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"informed consent"}}]}}